BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 6166945)

  • 21. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lateralization of striatal dopamine (D2) receptors in normal rats.
    Schneider LH; Murphy RB; Coons EE
    Neurosci Lett; 1982 Dec; 33(3):281-4. PubMed ID: 7162690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retina contains guanine nucleotide sensitive and insensitive classes of dopamine receptors.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Eur J Pharmacol; 1980 May; 63(2-3):217-22. PubMed ID: 6155277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3H-spiroperidol binding sites in blood platelets.
    Khanna AS; Agrawal AK; Seth PK
    Biochem Biophys Res Commun; 1987 Aug; 146(3):983-8. PubMed ID: 3619946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors.
    Palacios JM; Niehoff DL; Kuhar MJ
    Brain Res; 1981 Jun; 213(2):277-89. PubMed ID: 7248759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors.
    Köhler C; Hall H; Gawell L
    Eur J Pharmacol; 1986 Jan; 120(2):217-26. PubMed ID: 3948920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-2 dopamine receptors in the frontal cortex of rat and human.
    Liskowsky DR; Potter LT
    Life Sci; 1985 Apr; 36(16):1551-9. PubMed ID: 3982225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo modulation of brain dopamine recognition sites: a possible model for emission computed tomography studies.
    Ferrero P; Vaccarino F; Guidotti A; Costa E; Di Chiro G
    Neuropharmacology; 1983 Jun; 22(6):791-5. PubMed ID: 6604240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum.
    Huff RM; Molinoff PB
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7561-5. PubMed ID: 6961433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of serotonin receptors in rat uterus induced by estradiol.
    Ichida S; Tokunaga H; Oda Y; Fujita N; Hirata A; Hata T
    J Biol Chem; 1983 Nov; 258(22):13438-43. PubMed ID: 6643435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.